Multimodal supportive care therapy in cancer patients
Cancer supportive care: Weight loss, appetite loss, pain, nausea and vomiting, anxiety, insomnia
Potent, orally available, cannabinoidCB1/CB2 selective agonist with limited brain penetration
The multimodal potential of cannabinoids has been demonstrated both pre-clinically and clinically for many comorbid conditions encountered in cancer patients. Their clinical use, however, is limited due to the severity of central side effects.